A multimedia educational series is designed to provide patient education on cancer clinical trials.

The following topics are addressed:

• What is a clinical trial?
• Types of clinical trials.
• Phases of clinical trials.
• Benefits and drawbacks.
• Costs.
• FAQs. This section covers common myths and clarifies these myths using a Q&A format.
• How to join a clinical trial. Information about eligibility and informed consent.
• Clinical trial stories. Testimonies from oncology providers and patients. Each module is approximately 2-5 minutes, and they can be reviewed in the order/schedule preferred by the patient.

The overall program is 30 minutes to view including the videos. The tablet provided to patients provides additional benefits for participation.

The provider education intervention will consist of 3 provider informational sessions conducted individually. These individual provider sessions will be conducted by teleconference by the research team and scheduled according to provider's availability.

Provider workshops are designed to provide both a background on clinical trial infrastructure in Hawaii and resources for additional information. The content of these sessions includes:

• An overview of clinical trials infrastructure in Hawaii.
• Available trials in Hawaii. At each informational session, the research team will review available trials and any new/upcoming trials with the provider.
• An overview of how to get involved in clinical trials. As experience and background re: clinical trials may vary across providers, the content of these informational sessions will be tailored to each provider. Following the initial session, 2 additional meetings will be scheduled in 4-6 months as follow-up sessions.

Multimedia Educational Videos

Participants will complete a 12-item awareness and knowledge of clinical trials questionnaire at baseline and post-intervention. Items are reported on a Likert-type scale , with higher scores indicating greater knowledge. A paired t-test will be used to evaluate whether there is a statistically significant difference in pre- and post-intervention scores on patients' knowledge of clinical trials.